Cambridge Cognition Holdings plc, a neuroscience technology company specialising in digital cognitive assessments, has signed an agreement to expand in India.

The deal is with Ivory, a venture-backed brain health company headquartered in India, for the commercialisation of CANTAB Pathway across the healthcare and consumer health markets in the country.

Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment.